BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 27444927)

  • 1. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study.
    Narayan AK; Visvanathan K; Harvey SC
    Breast Cancer Res Treat; 2016 Aug; 158(3):583-9. PubMed ID: 27444927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
    Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored breast cancer screening program with microdose mammography, US, and MR Imaging: short-term results of a pilot study in 40-49-year-old women.
    Venturini E; Losio C; Panizza P; Rodighiero MG; Fedele I; Tacchini S; Schiani E; Ravelli S; Cristel G; Panzeri MM; De Cobelli F; Del Maschio A
    Radiology; 2013 Aug; 268(2):347-55. PubMed ID: 23579052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
    Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA
    J Prim Care Community Health; 2017 Apr; 8(2):55-62. PubMed ID: 27799412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
    Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
    Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.
    Le-Petross HT; Whitman GJ; Atchley DP; Yuan Y; Gutierrez-Barrera A; Hortobagyi GN; Litton JK; Arun BK
    Cancer; 2011 Sep; 117(17):3900-7. PubMed ID: 21365619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review.
    Raikhlin A; Curpen B; Warner E; Betel C; Wright B; Jong R
    AJR Am J Roentgenol; 2015 Apr; 204(4):889-97. PubMed ID: 25794083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion.
    Nadler M; Al-Attar H; Warner E; Martel AL; Balasingham S; Zhang L; Lipton JH; Curpen B
    Breast; 2017 Aug; 34():77-82. PubMed ID: 28527397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
    Lo G; Scaranelo AM; Aboras H; Ghai S; Kulkarni S; Fleming R; Bukhanov K; Crystal P
    Radiology; 2017 Oct; 285(1):36-43. PubMed ID: 28586291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
    Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
    J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
    Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First experiences in screening women at high risk for breast cancer with MR imaging.
    Tilanus-Linthorst MM; Obdeijn IM; Bartels KC; de Koning HJ; Oudkerk M
    Breast Cancer Res Treat; 2000 Sep; 63(1):53-60. PubMed ID: 11079159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.
    Obdeijn IM; Mann RM; Loo CCE; Lobbes M; Voormolen EMC; van Deurzen CHM; de Bock G; ; Hooning MJ
    Breast Cancer Res Treat; 2020 Jun; 181(3):581-588. PubMed ID: 32333294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
    Chiarelli AM; Blackmore KM; Muradali D; Done SJ; Majpruz V; Weerasinghe A; Mirea L; Eisen A; Rabeneck L; Warner E
    J Natl Cancer Inst; 2020 Feb; 112(2):136-144. PubMed ID: 31233143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
    Riedl CC; Luft N; Bernhart C; Weber M; Bernathova M; Tea MK; Rudas M; Singer CF; Helbich TH
    J Clin Oncol; 2015 Apr; 33(10):1128-35. PubMed ID: 25713430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
    Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
    Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.